1 |
Next generation therapeutics for retinal neurodegenerative diseases |
|
|
| Matthew B. Appell, Jahnavi Pejavar, Ashwin Pasupathy, Sri Vishnu Kiran Rompicharla, Saed Abbasi, Kiersten Malmberg, Patricia Kolodziejski, Laura M. Ensign |
|
| Journal of Controlled Release. 2024; 367: 708 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
LC/MS Assessment of Glycoform Clearance of a Biotherapeutic mAb in Rabbit Ocular Tissues |
|
|
| Shiyu Dong, Linzhi Chen, Achim Sauer, Lars Dittus |
|
| Journal of Pharmaceutical Sciences. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Targeting angiogenesis in oncology, ophthalmology and beyond |
|
|
| Yihai Cao, Robert Langer, Napoleone Ferrara |
|
| Nature Reviews Drug Discovery. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
A comparison between the effects of two liposome-encapsulated bevacizumab formulations on ocular neovascularization inhibition |
|
|
| Maryam Malakouti–Nejad, Daniela Monti, Susi Burgalassi, Hassan Bardania, Elahe Elahi, Dina Morshedi |
|
| Colloids and Surfaces B: Biointerfaces. 2023; : 113708 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence |
|
|
| Debdulal Chakraborty, Soumen Mondal, Subhendu Boral, Arnab Das, Tushar Kanti Sinha, Saptorshi Majumdar, Ranabir Bhattacharya, Ritobroto Maitra |
|
| Clinical Ophthalmology. 2023; Volume 17: 1067 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders |
|
|
| Abraham Hang, Samuel Feldman, Aana P. Amin, Jorge A. Rivas Ochoa, Susanna S. Park |
|
| Pharmaceuticals. 2023; 16(8): 1140 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration |
|
|
| Semra Ozdemir, Eric Finkelstein, Jia Jia Lee, Issac Horng Khit Too, Kelvin Yi Chong Teo, Anna Chen Sim Tan, Tien Yin Wong, Gemmy Chui Ming Cheung, Marie-Helene Errera |
|
| PLOS ONE. 2022; 17(8): e0272301 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
The Risk of Non-arteritic Ischemic Optic Neuropathy Post-intravitreal Bevacizumab Injection |
|
|
| Nasser A Fugara, Zaineh A Shawareb, Nancy K Rakkad, Manar L Barhoum, Bana A Shawareb, Myrna M Al-Madani, Mousa V Al-Madani |
|
| Cureus. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
Faricimab in the Treatment Landscape for Retinal Diseases: A Review |
|
|
| Anna K Wu, David D Chong, Rishi P Singh |
|
| US Ophthalmic Review. 2022; 16(2): 92 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Emergence of ocular toxicities associated with novel anticancer therapeutics: What the oncologist needs to know |
|
|
| Azka Ali, Ankit A. Shah, Lauren J. Jeang, Kyle S. Fallgatter, Thomas J. George, David L. DeRemer |
|
| Cancer Treatment Reviews. 2022; 105: 102376 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
Challenges and strategies for the delivery of biologics to the cornea |
|
|
| M. Wels, D. Roels, K. Raemdonck, S.C. De Smedt, F. Sauvage |
|
| Journal of Controlled Release. 2021; 333: 560 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Mapping of drug-related problems among older adults conciliating medical and pharmaceutical approaches |
|
|
| Marie-Laure Laroche, Thi Hong Van Ngo, Caroline Sirois, Amélie Daveluy, Michel Guillaumin, Marie-Blanche Valnet-Rabier, Muriel Grau, Barbara Roux, Louis Merle |
|
| European Geriatric Medicine. 2021; 12(3): 485 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis |
|
|
| Justus G. Garweg, Christin Gerhardt |
|
| Graefe's Archive for Clinical and Experimental Ophthalmology. 2021; 259(8): 2181 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care Formats |
|
|
| Paulina Jakubiak, Rubén Alvarez-Sánchez, Matthias Fueth, Olaf Broders, Hubert Kettenberger, Kay Stubenrauch, Antonello Caruso |
|
| Molecular Pharmaceutics. 2021; 18(6): 2208 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study |
|
|
| Shashikant Sharma, Vishali Gupta, Aniruddha Maiti, Sribhargava Natesh, Sandeep Saxena, Vivek Dave, Vimal Parmar, Raju Sampangi, Hemanth Murthy, Sandhya Dharwadkar, Naresh Kumar Yadav, Shrinivas Joshi, Rahul Mayor, Dhanashree Ratra, Soumyava Basu, Neha Goel, Alok Chaturvedi, Ronak Patel, Vinu Jose |
|
| International Journal of Retina and Vitreous. 2021; 7(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
16 |
Hydrogel Biomaterials for Application in Ocular Drug Delivery |
|
|
| Courtney R. Lynch, Pierre P. D. Kondiah, Yahya E. Choonara, Lisa C. du Toit, Naseer Ally, Viness Pillay |
|
| Frontiers in Bioengineering and Biotechnology. 2020; 8 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
17 |
Cell-based approaches towards treating age-related macular degeneration |
|
|
| Alireza Baradaran-Rafii, Masoumeh Sarvari, Sepideh Alavi-Moghadam, Moloud Payab, Parisa Goodarzi, Hamid Reza Aghayan, Bagher Larijani, Mostafa Rezaei-Tavirani, Mahmood Biglar, Babak Arjmand |
|
| Cell and Tissue Banking. 2020; 21(3): 339 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
18 |
Bevacizumab for eye diseases – Legal, regulatory, and ethical overview |
|
|
| Vinu Jose, Swetha Radhakrishna, Parag Pipalava, Inderjeet Singh |
|
| Indian Journal of Pharmacology. 2019; 51(6): 377 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
19 |
ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION IN THE ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ERA |
|
|
| Emily K. Tam, Pamela Golchet, Madeline Yung, Francis C. DeCroos, Marc Spirn, Lydia Lehmann-Clarke, Aude Ambresin, Irena Tsui |
|
| Retina. 2018; 38(2): 292 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
20 |
Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial |
|
|
| Arezoo Miraftabi, Naveed Nilforushan, Mina Darghahi, Sayyed Amirpooya Alemzadeh, Mohammad Parsamanesh, Maryam Yadgari |
|
| Clinical & Experimental Ophthalmology. 2018; 46(7): 750 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
21 |
Microspheres as intraocular therapeutic tools in chronic diseases of the optic nerve and retina |
|
|
| Irene Bravo-Osuna, Vanessa Andrés-Guerrero, Alicia Arranz-Romera, Sergio Esteban-Pérez, Irene T. Molina-Martínez, Rocío Herrero-Vanrell |
|
| Advanced Drug Delivery Reviews. 2018; 126: 127 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
22 |
Changing vision: a review of pharmacogenetic studies for treatment response in age-related macular degeneration patients |
|
|
| Janan Arslan, Paul N Baird |
|
| Pharmacogenomics. 2018; 19(5): 435 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
23 |
Pretreatment of RPE Cells with Lutein Can Mitigate Bevacizumab-Induced Increases in Angiogenin and bFGF |
|
|
| Natàlia Vilà, Jacqueline Coblentz, Carlos Moreira-Neto, Vasco Bravo-Filho, Pablo Zoroquiain, Miguel N. Burnier Jr. |
|
| Ophthalmic Research. 2017; 57(1): 48 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
24 |
Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy |
|
|
| K Ghasemi Falavarjani,M Hashemi,M Modarres,A Hadavand Khani |
|
| Eye. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
25 |
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration |
|
|
| Ciro Costagliola,Luca Agnifili,Barbara Arcidiacono,Sarah Duse,Vincenzo Fasanella,Rodolfo Mastropasqua,Marco Verolino,Francesco Semeraro |
|
| Expert Opinion on Biological Therapy. 2012; 12(10): 1299 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
26 |
Reduced occurrence of programmed cell death and gliosis in the retinas of juvenile rabbits after short-term treatment with intravitreous bevacizumab |
|
|
| Maria Alice Fusco, André Luís Freire Portes, Silvana Allodi, Haroldo Vieira de Moraes Junior, Mário Luiz Ribeiro Monteiro, Nádia Campos de Oliveira Miguel |
|
| Clinics. 2012; 67(1): 61 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
27 |
Perioperative use of bevacizumab in vitrectomy for proliferative diabetic retinopathy: A literature review |
|
|
| Falavarjani, K.G., Modarres, M. |
|
| Iranian Journal of Ophthalmology. 2010; 22(2): 5-12 |
|
| [Pubmed] [Google Scholar] |
|
28 |
Short-term response of macular oedema to intravitreal bevacizumab |
|
|
| Welch, D.E., Elmariah, H., Peden, M.C., Adams, S.G., Ratnakaram, R., Kaushal, S. |
|
| British Journal of Ophthalmology. 2009; 93(8): 1033-1036 |
|
| [Pubmed] [Google Scholar] |
|
29 |
Bevacizumab for ocular neovascular diseases: A systematic review |
|
|
| Andriolo, R.B., Puga, M.E., Beifort Jr., R., Atallah, Á.N. |
|
| Sao Paulo Medical Journal. 2009; 127(2): 84-91 |
|
| [Pubmed] [Google Scholar] |
|